S&OP and IBP for Pharma & Life Science

The marcus evans S&OP and IBP for Pharma & Life Science conference taking place on 23-25 March, 2026, in Frankfurt, Germany, will bring together senior leaders in supply chain, finance, and planning to explore how pharmaceutical and life sciences organizations are transforming S&OP/IBP to accelerate decision-making, enhance planning accuracy, and strengthen business alignment.

Key Topics Include: 

• Transform S&OP into IBP to Connect Strategy, Finance, and Execution
• Cross Functional Collaboration – Key for Successful S&OP/IBP
• Balance Short- and Long-Term Planning to Enable Strategic Alignment
• Leverage AI and Data to Strengthen S&OP and IBP Foundations
• Drive Change Management to Advance S&OP and IBP Maturity
• Align Portfolio and Demand to Build a Single Planning Narrative

Best Practices and Case Studies from: 

• Anastasia Dorizon, Head of IBP Governance and Implementation, Merck Life Science, Switzerland
• Tatjana Sretenovic-Rajicic, Head Global Demand Planning - Rare Disease, Bayer, Netherlands
• Claudia Lynn Martínez, Associate Director, New Product Planning and Portfolio Strategy (Food Allergy Therapy Area), Sanofi, Spain
• Flavia Rodrigues, Director Supply Chain Planning and Analytics, Bristol Myers Squibb, Switzerland
• Laura Santi, Head of Integrated Business Planning, Ipsen, France
• Agnieszka Romaniuk, Vice President Supply Chain, Thermo Fisher Scientific, Netherlands

Pharmiweb members are entitled to €200 discount! For more information please contact: Ria Kiayia, Marketing Manager, Digital Media and PR at riak@marcusevanscy.com or visit: https://bit.ly/43f4KrV